I am assuming commencement of trials isnt a typo and the 4 clin studies have been for other projects. Is bell potter in charge of the materials or is 4dx, whoever it is should be traded to cyclopharm for 3 interns, 7th round pick in 2026 and Jason horne-francis (so useless).
CT:VQ trials & submission in the medium term...
That would be a bloody quick turnaround time but what the market wants/needs to break free from the slump and generate actual momentum. 4DX is in a spot right now where we take 2 steps forward with a great announcement, 1 step diagonally back to the side and people try and salvage poor positions and get out, roll a dice with an arrow and take 1 step that way and get tripped up by day traders (kind of embarrassing actually) and then repeat. It's very different to dancing with the stars and impossible for the SP to have any material momentum.
That being said, if AF can trade his dancing shoes for some runners and do his best eliud kipchoge impersonation by delivering on ct:vq, SP will prepare for launch sequence to reach eventual orbital status.
Take any of my feedback with so much salt as I do also think the roos will be good next year. 1/2 on these predictions at least? What's another rebuilding year for the roos after all...
GLTAH and go Kangas!
4DX Price at posting:
55.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)